Overview and Key Facts
Squamous cell carcinoma (SCC) in dogs is an invasive epithelial cancer that arises from keratinizing squamous cells and typically affects the skin, oral cavity, nail beds (subungual), and sometimes the nasal planum or anus. It tends to occur in middle-aged to older dogs and is often locally aggressive, with metastasis risk depending on tumor site, size, and duration. Unlike some canine cancers that are strongly breed-predisposed, SCC is linked more to anatomical site and chronic inflammation or UV exposure. This guide explains the causes, clinical signs, diagnostic pathway, treatment options, and long-term outlook, emphasizing early recognition and tailored care coordinated with a veterinary oncologist or surgeon.
What Is Squamous Cell Carcinoma in Dogs
Squamous cell carcinoma is a malignant tumor derived from squamous epithelial cells, which form the outer layer of skin and mucous membranes. In dogs, SCC can manifest in several locations, each with distinct clinical behavior. Cutaneous (skin) SCC often appears as firm, nodular, crusted, or ulcerated lesions, frequently on lightly pigmented or sparsely haired regions such as the nose, eyelids, ears, and limbs. Oral SCC tends to be more aggressive, presenting as swellings, bleeding masses, or nonhealing ulcers in the mouth, and can impair eating and swallowing. Subungual SCC originates under the nail bed, causing lameness, swelling, and eventual digit destruction. Tumor grade, stage, and anatomic site strongly influence biological behavior and treatment response, making location a critical factor in prognosis and planning.
Recognizing the Symptoms
Cutaneous and Mucosal Signs
Owners may notice persistent, nonhealing sores, crusted or ulcerated patches, raised nodules, or areas of alopecia with scaling. These lesions can be variable in appearance and are often mistaken for benign inflammatory conditions initially. Key features that warrant prompt evaluation include lack of response to standard therapy (e.g., antibiotics), slow but progressive growth, bleeding, or pain on palpation. Tumors on sun-exposed areas such as the nose, pinnae, and around the eyes are particularly suspicious, especially in dogs with light-colored coats or those with chronic sun exposure. Mucosal SCC in the oral cavity may first appear as a firm plaque, a mass, or an ulcerative lesion that does not resolve with routine dental care.
Oral and Subungual Presentations
Oral SCC can cause halitosis, drooling, difficulty eating, weight loss, and visible masses on the gingiva, tongue, or tonsillar region. Dogs may drop food, prefer soft diets, or show reduced enthusiasm for chewing. Subungual SCC often presents as a firm mass under the nail, leading to lifting of the claw, swelling of the toe, intermittent lameness, and possible discharge or bleeding from the digit. Because these signs can overlap with infections, trauma, or less aggressive tumors, timely veterinary assessment and histopathologic confirmation are essential to avoid delays in diagnosis.
Causes and Risk Factors
The exact etiology of SCC in dogs is multifactorial, involving genetic susceptibility, chronic inflammation, and environmental exposures. Ultraviolet radiation is a well-established risk factor for cutaneous SCC, particularly in dogs with white or lightly pigmented coats that lack protective melanin. Chronic inflammation or irritation at sites such as the nasal planum, preauricular areas, or pressure points may predispose to tumor development. Viral factors such as papillomavirus infection have been investigated but are not considered a primary driver in most cases. Unlike some human SCCs linked to tobacco or strong viral associations, canine SCC is more closely tied to local trauma, chronic infection, and UV-induced DNA damage in keratinocytes. There is no clear evidence of strong breed predilection, but certain breeds with white coats or hairless regions may be more susceptible to sun-driven lesions.
Diagnosis and Staging
A definitive diagnosis of SCC requires histopathologic examination of a tissue sample obtained via incisional or excisional biopsy, depending on tumor size and location. Fine-needle aspiration of regional lymph nodes or organs may be used to assess regional spread. Staging typically includes baseline bloodwork (CBC, serum biochemistry, urinalysis), imaging of the thorax (chest radiographs or CT), and abdominal imaging when oral or invasive tumors are present. These steps help detect occult metastasis, particularly for oral and subungual SCC, which have a higher potential for regional and distant spread. Accurate staging informs treatment intensity and helps set realistic expectations for control and survival.
Treatment Approaches
Surgical Management
Surgery is often the cornerstone of therapy for localized, resectable SCC. The goal is to achieve wide margins with oncologic adequacy, guided by histopathologic assessment of excision borders. For cutaneous tumors on the extremities, limb salvage or digit amputation may be necessary when deep invasion is present. Oral SCC frequently requires partial or full-mouth extractions, jaw resections, or radical surgeries combined with reconstructive techniques when feasible. Surgery offers the best chance for local control when margins are clear, but owners should be counseled about functional and cosmetic outcomes, especially for large oral or facial defects.
Adjuvant and Definitive Radiotherapy
Adjuvant radiation therapy is commonly employed after incomplete surgical margins to improve local control and reduce recurrence risk. It is also used as definitive treatment when surgery is not feasible due to tumor location or patient comorbidities. Protocols vary by institution but often involve multiple fractions delivered over several weeks to maximize tumor control while sparing normal tissues. Side effects may include acute moist desquamation, mucositis, or temporary alopecia, depending on the field. Radiation can provide durable local control for many cutaneous and oral SCCs when appropriately planned.
Systemic and Palliative Options
For dogs with high-risk features, locoregional recurrence, or metastatic disease, systemic therapy may be considered. Options include chemotherapy (often palliative rather than curative), immunotherapy (such as tumor vaccines or checkpoint inhibitors in select cases), and targeted therapies when available within clinical trials. Pain management, nutritional support, and wound care are integral to maintaining quality of life. Multimodal approaches that combine surgery, radiation, and medical therapies are increasingly used for advanced cases, although outcomes vary by site and stage.
Prognosis and Monitoring
Prognosis for dogs with SCC is highly dependent on tumor location, size, completeness of excision, and presence of metastasis. Cutaneous SCC on non-muco-cutaneous sites has a more favorable outlook when completely excised with clear margins. Oral and subungual SCC carry a guarded prognosis due to local invasiveness and higher metastatic potential. Regular recheck examinations, imaging when indicated, and monitoring for new lesions are essential components of follow-up. Owners should be advised about the importance of early referral for recurrence or new signs to optimize secondary intervention options.
Practical Takeaways for Owners and Caregivers
- Prompt evaluation of new, persistent, or nonhealing skin or mucosal lesions improves the likelihood of curative-intent treatment.
- Sun protection for white or lightly pigmented dogs, including sunscreen and limited sun exposure, may reduce risk of cutaneous SCC on exposed areas.
- Definitive diagnosis via biopsy is required; fine-needle aspiration alone is insufficient to confirm SCC.
- Treatment is multimodal, often combining surgery, radiation, and medical therapies tailored to tumor site and stage.
- Long-term outcomes depend heavily on early detection, complete excision, and adherence to surveillance plans.
Summary
Squamous cell carcinoma in dogs is an important and locally aggressive malignancy that varies by site and behavior. With thorough diagnostic staging, appropriate surgical, radiation, and medical management, many dogs can achieve durable local control and good quality of life. Understanding the role of location, margins, and multimodal therapy helps owners and clinicians make informed decisions. Ongoing monitoring and early intervention remain cornerstones of long-term success, reinforcing the value of consistent veterinary care for dogs at risk or affected by SCC.